number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide What Are the New Medications? From 'companion foods' to 'Nature's

Designed for people who have plateaued or want a more assertive GLP-1 path

Richard A

FDA Approval Criteria: For FDA approval as weight loss medication, drugs must demonstrate: Efficacy Requirements: At least 5% average weight loss greater than placebo At least 35% of patients lose 5% body weight At least 15% of patients lose 10% body weight Safety Requirements: Acceptable safety profile in clinical trials Benefits outweigh risks Appropriate for long-term use All newer GLP-1 medications far exceed the minimum efficacy requirements, which explains their dominance

Support team depth

Liraglutide (Victoza, Saxenda) Approved for obesity at higher doses, typically results in 57% weight loss

Read the specific terms carefully, as the guarantee may not apply if you skip doses, do not attend follow-ups, or deviate from the prescribed protocol